Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis reduces unnecessary referrals

Clicks: 4
ID: 325118
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #33 of 46 articles by views in Rheumatology Advances in Practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Objectives Rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPA) are alternative diagnostic tests for rheumatoid arthritis with similar sensitivity. ACPA has improved specificity compared with RF and so should result in fewer false positives. A retrospective, observational study was conducted following a change in the primary care pathway and test for inflammatory arthritis from RF to ACPA, assessing real-world impact on referrals. Methods The primary care test was changed from RF to ACPA as part of a service development in East and North Devon, UK (population 463,000). Data were monitored post-implementation from 1st March to 31st August 2024. ACPA was made available to primary care. GP order-comms automatically redirected requests for RF to ACPA. Local referral guidelines were implemented recommending ACPA to support referral decisions but not for rule-out of inflammatory arthritis. The equivalent six-month period from 2023 when RF was the primary test for inflammatory arthritis was used for comparison. Results Positive tests fell from 10.6% with RF to 3.9% with ACPA. This led to 57 (39%) fewer referrals following a positive test. The false positive rate amongst those referred to rheumatology decreased from 59% (91/148) with RF to 32% (29/91) with ACPA. ACPA and RF detected similar numbers of inflammatory arthritis cases with a case yield of 2.1% for both tests. Conclusion Replacement of RF with ACPA within a redesigned inflammatory arthritis pathway reduced unnecessary rheumatology referrals. This could help over-subscribed services reduce waiting times and therefore contribute to timely diagnosis of inflammatory arthritis.
Reference Key
openalex_W7203632516 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors G Allen, Timothy J. McDonald, Stuart Kyle, Nick Keysell
Journal Rheumatology Advances in Practice
Year 2026
DOI
10.1093/rap/rkag103
URL
https://doi.org/10.1093/rap/rkag103
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.